Skip to content

The Effects of Central Pathway and Postural Control (CPPC) Technology on Balance Function, Transfer Function and Activities of Daily Living in Stroke Patients

The Effects of Central Pathway and Postural Control (CPPC) Technology on Balance Function, Transfer Function and Activities of Daily Living in Stroke Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117913
Enrollment
Unknown
Registered
2026-01-30
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Experimental group:CPPC technology and conventional rehabilitation

Sponsors

Chaohu Hospital Affiliated to Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Diagnostic criteria: Must meet the diagnostic criteria for stroke (including ischemic and hemorrhagic types) as outlined in "Key Points for Diagnosis of Various Cerebrovascular Diseases", and be confirmed by cranial CT or MRI examination; 2. Disease course stage: First onset, with a disease duration of less than 6 months, and unilateral limb paralysis exists; 3. Age range: 18-79 years old, gender not restricted; 4. Functional impairment: There is clear balance and transfer dysfunction (Berg Balance Scale score ranging from 10 to 40); 5. Capable of understanding and cooperating with simple instructions (Mini-Mental State Examination MMSE = 24 points).

Exclusion criteria

Exclusion criteria: 1. Severe dysfunction of the heart, lungs, liver, kidneys or other serious internal diseases; 2. Accompanied by other neurological diseases such as Parkinson's disease, spinal cord injury, Alzheimer's disease, etc. that severely affect balance and motor functions; 3. The affected limb has severe joint contractures, deformities, and pain, and is unable to undergo functional training; 4. Has a history of epilepsy, brain surgery, or is intolerant to transcranial magnetic therapy; 5. Severe cognitive or communication disorders, unable to cooperate with assessment and training; 6. Participates in other clinical trials that may affect the results of this study.

Design outcomes

Primary

MeasureTime frame
Berg balance scale;Posture control function test;Mobility Ability Test;Gait analysis;

Countries

China

Contacts

Public ContactShi Xiongfei

Chaohu Hospital Affiliated to Anhui Medical University

3838043757@qq.com+86 183 5601 8827

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026